Xufei Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xufei Chen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Linhong Huang
Hong-Hui Hospital, Xi'an Jiaotong University College of Medicine, Xi'an 710054, PR China
1 shared publication - Xiaohui Zheng
Key Laboratory of Resource Biology and Modern Biotechnology in Western China, The College of Life Science, Northwest University, Xi'an, Shaanxi, 710069, China
1 shared publication - Xirui He
Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai 519041, China
1 shared publication - Yajun Bai
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, The College of Life Sciences
1 shared publication - Ye Cuan
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, The College of Life Sciences, Northwest University, 229 Taibai Road, Xi’an 710069, China
1 shared publication - Ying Sun
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, 229 Taibai Road, Xi’an 710069, China
1 shared publication
Latest Publications
- Open Access
Phytochemistry, Pharmacology and Traditional Uses of Plants from the Genus Trachelospermum L.
This paper is intended to review advances in the botanical, phytochemical, traditional uses and pharmacological studies of the genus Trachelospermum. Until now, 138 chemical constituents have been isolated and characterized from these plants, particularly from T. asiaticum and T. jasminoides. Among these compounds, lignans, triterpenoids, and flavonoids are the major bioactive constituents. Studies have shown that plants from the genus Trachelospermum exhibit an extensive range of pharmacological properties both in vivo and in vitro, including anti-inflammatory, analgesic, antitumor, antiviral and antibacterial activities. In Traditional Chinese Medicine (TCM) culture, drugs that include T. jasminoides stems have been used to cure rheumatism, gonarthritis, backache and pharyngitis, although there are few reports concerning the clinical use and toxicity of these plants. Further attention should be paid to gathering information about their toxicology data, quality-control measures, and the clinical value of the active compounds from genus Trachelospermum.
Open AccessPhytochemistry, Pharmacology and Traditional Uses of Plants from the Genus Trachelospermum L.
This paper is intended to review advances in the botanical, phytochemical, traditional uses and pharmacological studies of the genus Trachelospermum. Until now, 138 chemical constituents have been isolated and characterized from these plants, particularly from T. asiaticum and T. jasminoides. Among these compounds, lignans, triterpenoids, and flavonoids are the major bioactive constituents. Studies have shown that plants from the genus Trachelospermum exhibit an extensive range of pharmacological properties both in vivo and in vitro, including anti-inflammatory, analgesic, antitumor, antiviral and antibacterial activities. In Traditional Chinese Medicine (TCM) culture, drugs that include T. jasminoides stems have been used to cure rheumatism, gonarthritis, backache and pharyngitis, although there are few reports concerning the clinical use and toxicity of these plants. Further attention should be paid to gathering information about their toxicology data, quality-control measures, and the clinical value of the active compounds from genus Trachelospermum.